Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Successful caspofungin treatment of persistent candidemia in extreme prematurity at 23 and 24 weeks' gestation.

Jeon GW, Sin JB.

J Formos Med Assoc. 2014 Mar;113(3):191-4. doi: 10.1016/j.jfma.2014.01.003. Epub 2014 Feb 15.

2.

Disseminated candidemia refractory to caspofungin therapy in an infant with extremely low birth weight.

Li MJ, Hsueh PR, Lu CY, Chou HC, Lee PI, Chang LY, Huang LM.

J Formos Med Assoc. 2012 Jan;111(1):46-50. doi: 10.1016/j.jfma.2012.01.005. Epub 2012 Feb 2.

3.

Caspofungin for the treatment of azole resistant candidemia in a premature infant.

Smith PB, Steinbach WJ, Cotten CM, Schell WA, Perfect JR, Walsh TJ, Benjamin DK Jr.

J Perinatol. 2007 Feb;27(2):127-9.

PMID:
17262048
4.

Experience with caspofungin in the treatment of persistent fungemia in neonates.

Natarajan G, Lulic-Botica M, Rongkavilit C, Pappas A, Bedard M.

J Perinatol. 2005 Dec;25(12):770-7.

PMID:
16222348
5.

[Successful caspofungin treatment of invasive refractory candidiasis in the extremely low birthweight neonate].

Lopes A, Rocha G, Vilan A, Guedes MB, Guimarães H.

Acta Med Port. 2010 Jul-Aug;23(4):719-22. Epub 2010 Jul 30. Portuguese.

6.

Successful caspofungin treatment of multidrug resistant Candida parapsilosis septicaemia in an extremely low birth weight neonate.

Yalaz M, Akisu M, Hilmioglu S, Calkavur S, Cakmak B, Kultursay N.

Mycoses. 2006 May;49(3):242-5.

PMID:
16681818
7.

Candida fermentati as a cause of persistent fungemia in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.

Al-Sweih N, Ahmad S, Joseph L, Khan S, Vayalil S, Chandy R, Khan Z.

J Clin Microbiol. 2015 Mar;53(3):1038-41. doi: 10.1128/JCM.03351-14. Epub 2015 Jan 7.

8.

Persistent Candida conglobata bloodstream infection in a preterm neonate successfully treated by combination therapy with amphotericin B and caspofungin.

Al-Sweih N, Ahmad S, Khan S, Khan Z, Joseph L, Vayalil S, Chandy R.

J Mycol Med. 2017 Jun;27(2):271-276. doi: 10.1016/j.mycmed.2017.01.010. Epub 2017 Feb 9.

PMID:
28189376
9.

Neonatal liver abscesses due to Candida infection effectively treated with caspofungin.

Filippi L, Poggi C, Gozzini E, Meleleo R, Mirabile L, Fiorini P.

Acta Paediatr. 2009 May;98(5):906-9. doi: 10.1111/j.1651-2227.2009.01225.x. Epub 2009 Feb 2.

PMID:
19187395
10.

Combination antifungal therapy with voriconazole for persistent candidemia in very low birth weight neonates.

Turan O, Ergenekon E, Hirfanoğlu IM, Onal EE, Baş VN, Türkyilmaz C, Koç E, Atalay Y.

Turk J Pediatr. 2011 Jan-Feb;53(1):19-26.

PMID:
21534335
11.

Caspofungin therapy of neonates with invasive candidiasis.

Odio CM, Araya R, Pinto LE, Castro CE, Vasquez S, Alfaro B, Sàenz A, Herrera ML, Walsh TJ.

Pediatr Infect Dis J. 2004 Dec;23(12):1093-7.

PMID:
15626944
12.

Efficacy of micafungin in invasive candidiasis caused by common Candida species with special emphasis on non-albicans Candida species.

Cornely OA, Vazquez J, De Waele J, Betts R, Rotstein C, Nucci M, Pappas PG, Ullmann AJ.

Mycoses. 2014 Feb;57(2):79-89. doi: 10.1111/myc.12104. Epub 2013 Jun 20.

PMID:
23786573
13.

Successful treatment of an infant infected with refractory C. parapsilosis with caspofungin.

Ozkaya-Parlakay A, Tezer H, Kazmacan T, Gulhan B, Unal S.

J Trop Pediatr. 2014 Aug;60(4):329-30. doi: 10.1093/tropej/fmu014. Epub 2014 Feb 24.

PMID:
24567311
14.
15.

Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant.

Natale F, Castronovo A, Regoli D, De Curtis M, Manzoni P.

Pediatr Infect Dis J. 2009 May;28(5):452. doi: 10.1097/INF.0b013e31819d1cf1. No abstract available.

PMID:
19295457
16.

Refractory neonatal candidemia and high-dose micafungin pharmacotherapy.

Natarajan G, Lulic-Botica M, Aranda JV.

J Perinatol. 2009 Nov;29(11):738-43. doi: 10.1038/jp.2009.75. Epub 2009 Sep 24.

PMID:
19776753
17.

Efficacy of micafungin in treating four premature infants with candidiasis.

Kawaguchi C, Arai I, Yasuhara H, Sano R, Nishikubo T, Takahashi Y.

Pediatr Int. 2009 Apr;51(2):220-4. doi: 10.1111/j.1442-200X.2008.02726.x.

PMID:
19405920
18.

Risk factors of mortality and comparative in-vitro efficacy of anidulafungin, caspofungin, and micafungin for candidemia.

Lee SC, Lee CW, Shih HJ, Huang SH, Chiou MJ, See LC.

J Microbiol Immunol Infect. 2014 Jun;47(3):245-53. doi: 10.1016/j.jmii.2013.09.006. Epub 2013 Nov 15.

19.

Candida and candidaemia. Susceptibility and epidemiology.

Arendrup MC.

Dan Med J. 2013 Nov;60(11):B4698. Review.

PMID:
24192246
20.

Empirical therapy for neonatal candidemia in very low birth weight infants.

Benjamin DK Jr, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH.

Pediatrics. 2003 Sep;112(3 Pt 1):543-7.

PMID:
12949281

Supplemental Content

Support Center